Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Secukinumab can cause hair loss, which may improve after stopping the medication.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

Nail changes are common in alopecia areata and can indicate its severity.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

People with alopecia areata have a higher risk of heart disease.